Febuxostat (Adenuric): increased risk of cardiovascular death and all-cause mortality in clinical trial in patients with a history of major cardiovascular disease
CrossRef Position paper of the European Society of Cardiologyworking group of coronary pathophysiology and microcirculation: obesity and heart disease Lina Badimon, Raffaele Bugiardini, Edina Cenko, Judit Cubedo, Maria Dorobantu, Dirk J
Beta-blockers may mask the adrenergic symptoms of hypoglycemia (trembling, palpitations), making early recognition more difficult
These medications include semaglutide (Wegovy, approved for weight management
Our program combines compounded semaglutide or tirzepatide with nutrition guidance, lifestyle support, and ongoing medical oversight
Clinical research directly addressing cold sensitivity with tirzepatide remains limited